GWN Securities’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
GWN Securities's NVO Position: Q2 2026 in Review
GWN Securities opened a new position in Novo Nordisk (NVO) in Q2 2026: 4,372 shares worth $210K. The stake represents 0.04% of the portfolio and ranks #472 among its holdings. This is a return to the name: GWN Securities previously reported a position in NVO as recently as Q2 2025.
GWN Securities first reported a position in NVO in Q4 2024 and has held it in 4 quarters since. The position peaked at $468K in Q1 2025. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- GWN Securities held 4,372 shares of Novo Nordisk worth $210K as of Q2 2026.
- Novo Nordisk was a new GWN Securities position in Q2 2026.
- Novo Nordisk made up 0.04% of GWN Securities's portfolio in Q2 2026, its #472 holding.
- GWN Securities first reported a position in Novo Nordisk in Q4 2024 and has held it in 4 quarters since.
- GWN Securities's Novo Nordisk position peaked at $468K in Q1 2025.
- 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on GWN Securities's 13F filing for Q2 2026, filed 5 Aug 2026.